COX2, HBF-EFG, and ST6GalNac5 may enable cancer cells to cross the blood-brain barrier” />

Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Gynecology | Internal Medicine | Neurology | Oncology | Pathology | Journal

Back to Journal Articles

Three Genes Linked to Breast Cancer Metastases

Last Updated: May 08, 2009.

 

COX2, HBF-EFG, and ST6GalNac5 may enable cancer cells to cross the blood-brain barrier

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Three different genes may mediate the spread of breast cancer to the brain, according to a study published online May 6 in Nature.

FRIDAY, May 8 (HealthDay News) -- Three different genes may mediate the spread of breast cancer to the brain, according to a study published online May 6 in Nature.

Paula D. Bos, of the Memorial Sloan-Kettering Cancer Center in New York City, and colleagues isolated brain-targeting cancer cells from women with advanced disease, performed gene-expression profiling, and inoculated immunodeficient female mice with CN34 and MDA231 cells.

The researchers found that two genes that promote cancer cell mobility and invasiveness -- COX2 and HB-EGF -- are genetic mediators of brain metastases. They also found that a third gene -- ST6GalNac5 -- is responsible for a chemical reaction that coats breast cancer cells with an enzyme that enables them to cross the blood-brain barrier.

"These findings draw attention to the role of cell surface sialylation as a previously unrecognized participant in brain metastasis, and to the possibility of therapeutically disrupting these interactions," the authors write. "Our work also points at other candidate brain metastasis genes, including genes implicated in vascular permeability and leukocyte infiltration during brain inflammatory processes, and genes implicated in neurite extension and astrocyte cell processes. The role of these genes in brain metastasis and their interest as therapeutic targets is open to further analysis."

Abstract
Full Text (subscription or payment may be required)

Copyright © 2009 ScoutNews, LLC. All rights reserved.


Previous: Death Rate After Ablation of Atrial Fibrillation 1 in 1,000 Next: Monthly Testosterone Effective as a Male Contraceptive

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.